Evidence map›Paper›PMID 36980795›Full record

ArticleCancers2023

Examination of the Functional Relationship between

Trine V Larsen, Nina Dybdal, Tina F Daugaard, Johanne Lade-Keller, Lin Lin, Boe S Sorensen, Anders L Nielsen

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Unlocking Lung Cancer Cell Dormancy: An Epigenetic Perspective.International journal of molecular sciences · 2025
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Trine V LarsenDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Nina DybdalDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Tina F DaugaardDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Johanne Lade-KellerDepartment of Pathology, Aarhus University Hospital, 8200 Aarhus, Denmark.ORCID 0000-0001-7946-2483
Lin LinDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Boe S SorensenDepartment of Clinical Biochemistry, Aarhus University Hospital, 8200 Aarhus, Denmark.ORCID 0000-0002-9472-8099
Anders L NielsenDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Aarhus University · DKAarhus University Hospital · DK

Funding

CSRD VA 1Dagmar Marshalls Mindelegat 2Fabrikant Einar Willumsens Mindelegat 3Familien Erichsens Familiefond 7Kræftfonden 8Marie og Børge Kroghs Fond 4P. A. Messerschmidt og Hustrus Fond 5Thora og Viggo Grove's Mindelegat 6
6 · The paper itself

Abstract

Immunotherapy targeting the interaction between programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) is a treatment option for patients with non-small-cell lung cancer (NSCLC). The expression of PD-L1 by the NSCLC cells determines treatment effectiveness, but the relationship between

Indexed as

biomarkerDNA methylationepigeneticsimmunotherapylung cancerPD-L1

Identifiers

PMID36980795
PMCPMC10047551
OpenAlexW4353066330

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read41
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.